Guided by nature.
Realized through science.

What We Do

Systemic interactions are fundamental to human biology, from drug discovery to tissue regeneration. Through expert integration of systemic physiology, Xylyx Bio develops and translates cutting-edge regenerative biotechnologies into first-in-class products and services with real-world impact.


Xylyx Bio is led by global thought leaders with decades of industry experience and deep domain expertise across science, medicine, and business. Interdisciplinary collaboration between specialties and institutions has led to the creation of a diverse and talented team committed to advancing the field of regenerative medicine.


Board of Directors

Anthony Curro, MBA


Matt Bacchetta, MD, MBA, FACS

Andrea Nye, MPH, MBA

Gordana Vunjak-Novakovic, PhD

Chair Emeritus


Matt Bacchetta, MD, MBA, FACS

Professor of Cardiac Surgery, Thoracic Surgery, and Biomedical Engineering; H. William Scott, Jr. Chair in Surgery; Surgical Director, Vanderbilt Respiratory Institute; Director, ECMO Program; Director, Laboratory for Organ Regeneration, Recovery, and Replacement, Vanderbilt University

Brandon Guenthart, MD

Clinical Assistant Professor of Cardiothoracic Surgery; Director, Lung Recovery and Bioengineering Laboratory, Stanford University

Jinho Kim, PhD

Assistant Professor of Biomedical Engineering; Director, Translational Lung Bioengineering Laboratory, Stevens Institute of Technology

Ken Reed, MD

Board-Certified Dermatologist and Mohs Surgeon; Co-Founder of DermAsap, Early Cell, and Lispiro

Gordana Vunjak-Novakovic, PhD

Mikati Foundation Professor of Biomedical Engineering and University Professor of Medical Sciences; Director, Laboratory for Stem Cells and Tissue Engineering, Columbia University

Partner with us to advance regenerative medicine

Xylyx Bio is driving real-world impact through research and development partnerships. Encouraged by the resounding success of our ongoing collaborations with academic and industry partners, we continue to seek dedicated partners who share our mission of saving and improving human lives through the development of transformative medical technologies.


Stay up to date on Xylyx Bio

Read more

Aug. 1, 2023

Xylyx Bio and Alec Batis partner to launch Sweet Chemistry, a groundbreaking line of evidence-based regenerative skincare products

Read more

June 6, 2023

Guide to Extracellular Matrices (and How to Avoid Common Problems)

Read more

April 19, 2023

Xylyx Bio Matrikynes Exhibits Clinical Anti-aging, Barrier Repair Efficacy

Read more
Xylyx Bio’s proprietary Matrikynes® ingredient is safe and highly effective for anti-aging and other topical skin applications.

April 5, 2023

Clinical study shows Xylyx Bio’s Matrikynes® significantly improves the structure, function, and appearance of skin

Read more
Xylyx Bio launches new website to showcase growing portfolio of regenerative biotechnologies.

Feb. 28, 2023

Xylyx Bio launches new website to showcase growing portfolio of regenerative biotechnologies

Read more
Human Donor Lung Rehabilitation and Recovery

Jan. 23, 2023

Researchers confirm successful rehabilitation and recovery of human donor lungs previously deemed unfit for transplant

Read more

Sept. 6, 2022

Choosing Extracellular Matrix for Cultured Cells

Read more

April 5, 2022

Xylyx Bio collaboration reveals new insights into tumor drug resistance

Read more
Xylyx Bio Awarded $2.2M NIH SBIR Fast-Track Grant from National Heart, Lung, and Blood Institute

Sept. 2, 2021

Xylyx Bio Awarded $2.2M NIH SBIR Fast-Track Grant from National Heart, Lung, and Blood Institute

Read more
The ultimate ex vivo lung perfusion: Xenogeneic cross-circulation

Aug. 21, 2021

The ultimate ex vivo lung perfusion: Xenogeneic cross-circulation

Read more

Aug. 7, 2020

Living pig bioreactors can repair damaged donor lungs

Read more

July 13, 2020

In Astounding Test, Scientists Revive Damaged Lungs for Transplant

Contact us

Get in touch

760 Parkside Avenue
Brooklyn, NY 11226

+1 (212) 689-9005